Pathways’ Picks October 10: The News this Week


Welcome to the October 10 edition of Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: the Trump administration tries to add legal clarity for value-based contracts, the first notified body is designated for the EU IVD Regulation, updates from China and India agencies, dates to remember, and more.

Medtech firms were hoping for more legal assurances to support setting up value-based, risk-sharing contracts with hospitals and others in two proposed rules dropped by the Trump administration October 9. It is not clear that they have gotten it yet. That news leads our Pathways’ Picks—a rundown of medtech policy items and key dates that should be on your radar this week. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: